SCHEMBL24504035

SCHEMBL24504035

CCCOc1ccc(/C=C2\S/C(=N\Cc3ccc(OC)cc3)N(CC(C)C)C2=O)cc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ MAPT P10636 5/20 0.51
▸ HPGD P15428 1/20 0.51
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ NPSR1 Q6W5P4 3/20 0.48
▸ POLB P06746 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.46
▸ PTGES O14684 1/20 0.41
▸ PTPN2 P17706 3/20 0.41
▸ PTPN1 P18031 3/20 0.41
▸ ACP1 P24666 3/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ S1PR3 Q99500 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MGAM O43451 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19096372 0.81 CFTR (0.52) ALDH1A1MAPTHPGDCYP3A4CYP2C9
SCHEMBL19096626 0.70 CFTR (0.53) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL19096416 0.65 FAAH (0.50) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL19096234 0.65 S1PR1 (0.44) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL17302129 0.64 S1PR1 (0.70) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL20582539 0.64 S1PR1 (0.67) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL19096576 0.64 S1PR1 (0.55) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL17309309 0.63 CA9 (0.76) ALDH1A1MAPTHPGDCYP3A4CYP2C9
SCHEMBL19481512 0.63 CA9 (0.76) ALDH1A1MAPTHPGDCYP3A4CYP2C9
SCHEMBL19096560 0.63 S1PR1 (0.49) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4011879-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2022-06-15 — — EP disclosed
Send feedback